Advances in Endoscopic Ultrasound in Pancreatic Cancer Screening, Diagnosis, and Palliative Care by Wenyu Zhang, Jingzheng Chen, Wei Zhang, Min Xu

Subjects: Get full text

Editorial: Advances in immunotherapy of hepatic-biliary-pancreatic cancers, volume II by Hu Jiaming, Zhang Minghui, Liu Huiqiang, Zhang Zongli, Xu Yunfei

Get full text

The Natural History of Pancreatic Cancer in Manitoba: A Population Based Study by Jack Martin, Brian H Weinerman

Get full text

Pancreatic Cancer in Canada: Incidence and Mortality Trends from 1992 to 2005 by Robert Flook, Sander Veldhuyzen van Zanten

“…BACKGROUND: Pancreatic cancer is the fourth-ranking cause of death among all major malignancies in Canada and has the lowest five-year survival rate.…”
Get full text

MicroRNAs in pancreatic cancer drug resistance: mechanisms and therapeutic potential by Fangying Dong, Jing Zhou, Yijie Wu, Zhaofeng Gao, Weiwei Li, Zhengwei Song

Subjects: “…pancreatic cancer…”
Get full text

Biliary drainage in pancreatic cancer with duodenal invasion: which route is the best? by Tanyaporn Chantarojanasiri, Thawee Ratanachu-Ek

Get full text

Possibilities of palliative chemotherapy in patients with locally advanced and metastatic pancreatic cancer by L. I. Moskvicheva, L. V. Bolotina

Subjects: “…locally advanced and metastatic pancreatic cancer…”
Get full text

Harnessing dendritic cells for pancreatic cancer immunotherapy: a novel promising approach by Hui Zeng, Yidong Wu, Xinghua Long

Get full text

EI24 Suppresses Tumorigenesis in Pancreatic Cancer via Regulating c-Myc by Yi Zang, Lei Zhu, Tong Li, Qi Wang, Juanjuan Li, Yuting Qian, Lumin Wei, Mingping Xie, Wen-Hao Tang, Xu Liu, Ying Zhu, Lifu Wang

“…Together, we propose that EI24 suppresses cell proliferation and prompts cell cycle arrest in pancreatic cancer cells by activating the autophagic lysosomal degradation of c-Myc. …”
Get full text

Intratumoral <i>Fusobacterium nucleatum</i> in Pancreatic Cancer: Current and Future Perspectives by Domenica Lucia D’Antonio, Anna Zenoniani, Samia Umme, Adriano Piattelli, Maria Cristina Curia

Subjects: Get full text

Charlson syndrome index predicted survival in pancreatic cancer patients received immunotherapy by Nan Zhang, Nan Zhang, Shiyun Chen, Yue Shi, Zhikuan Wang, Ru Jia, Guanghai Dai, Guanghai Dai

Subjects: “…pancreatic cancer…”
Get full text

Metastatic pancreatic cancer now in remission: a case report and literature review by Charles W. Shi, Thomas J. VanderMeer, Anita Pudusseri

“…Abstract Pancreatic cancer is a highly aggressive malignancy with the majority of patients presenting at a late stage with unresectable or metastatic disease. …”
Get full text

OSBPL3 modulates the immunosuppressive microenvironment and predicts therapeutic outcomes in pancreatic cancer by Qihui Sun, Xiaoqi Zhu, Qi Zou, Yang Chen, Tingting Wen, Tingting Jiang, Xiaojia Li, Fang Wei, Keping Xie, Jia Liu

“…Abstract Background Pancreatic cancer is characterized by a complex tumor microenvironment that hinders effective immunotherapy. …”
Get full text

THE POSSIBILITIES OF MODERN METHODS OF ABLATION IN NON-RESECTABLE LOCALLY ADVANCED PANCREATIC CANCER by L. I. Moskvicheva, L. O. Petrov, D. V. Sidorov

Subjects: “…unresectable locally advanced pancreatic cancer…”
Get full text

A stumbling block in pancreatic cancer treatment: drug resistance signaling networks by Jinming Liu, Biao Zhang, Bingqian Huang, Kexin Zhang, Fujia Guo, Zhizhou Wang, Dong Shang, Dong Shang

Subjects: “…pancreatic cancer…”
Get full text

Endoscopic biliary drainage for distal bile duct obstruction due to pancreatic cancer by Masahiro Itonaga, Masayuki Kitano

“…Approximately 60% of pancreatic cancers occur in the pancreatic head and may present as obstructive jaundice due to bile duct invasion. …”
Get full text

Preliminary Results of Hyperthermic Intraperitoneal Intraoperative Chemotherapy as an Adjuvant in Resectable Pancreatic Cancer by Antonios-Apostolos K. Tentes, Dimitrios Kyziridis, Stylianos Kakolyris, Nicolaos Pallas, Georgios Zorbas, Odysseas Korakianitis, Christos Mavroudis, Nicolaos Courcoutsakis, Panos Prasopoulos

“…Background and Aims. 5-year survival in patients with pancreatic cancer is poor. Surgical resection is the only potentially curative resection. …”
Get full text

Efficacy of natural killer T and gammadelta T cells in mesothelin-targeted immunotherapy of pancreatic cancer by Yuankui Zhu, Yaxi Yang, Linghe Yue, Lei Wan, Xuqian Ma, Qing Yang, Xuan Tian, Yuguan Li, Ke Wang, Shaozhong Wei, Shaozhong Wei, Shaozhong Wei, Dianbao Zuo, Mingqian Feng, Mingqian Feng

“…Current pancreatic cancer immunotherapy focused on alphabeta (αβ) T cells, either through CD3-engaged bispecific antibodies or CAR-T. …”
Get full text

Correction: Engineered a dual-targeting biomimetic nanomedicine for pancreatic cancer chemoimmunotherapy by Meng Wang, Qida Hu, Junmin Huang, Xinyu Zhao, Shiyi Shao, Fu Zhang, Zhuo Yao, Yuan Ping, Tingbo Liang

Get full text

ENO1 Overexpression in Pancreatic Cancer Patients and Its Clinical and Diagnostic Significance by Hang Yin, Lei Wang, Hai-Lin Liu

Get full text